MAGEA11 and gastric cancer: Preliminary studies support that PF-04217903, 4SC-202, Indibulin, Tipifarnib, ETHINYL ESTRADIOL, and Okadaic acid can target MAGEA11, which is expected to make new progress in gastric cancer treatment.